Related by context. All words. (Click for frequent words.) 80 colorectal cancers 76 breast cancers 76 prostate cancers 75 ovarian cancer 74 cancers 73 colon cancers 73 lung cancers 72 colorectal cancer 72 bladder cancers 72 endometrial cancers 71 pancreatic cancers 68 bowel cancers 68 melanoma 67 uterine cancers 67 testicular cancers 66 cervical cancers 66 melanomas 66 malignancies 66 breast tumors 65 breast cancer 65 ovarian tumors 65 gastric cancer 65 colorectal cancer CRC 64 tumors 64 colon cancer 64 cervical cancer 64 endometrial cancer 64 breast ovarian 64 malignancy 64 invasive breast cancer 63 BRCA2 mutations 63 lung tumors 63 gastric cancers 63 hereditary breast cancer 63 gastrointestinal cancers 62 lung cancer 62 prostate cancer 62 adenocarcinomas 62 basal cell carcinomas 62 prostate tumors 62 gynecological cancers 62 BRCA mutations 62 invasive cervical cancer 61 adenocarcinoma 61 HER2 positive breast cancer 61 thyroid cancers 61 malignant melanoma 61 gynecologic cancers 61 colon tumors 61 metastases 61 lymphomas 61 colorectal tumors 61 metastatic cancer 61 neuroendocrine tumors 61 anal cancers 61 adenomatous polyps 61 pre cancerous lesions 61 GISTs 61 skin cancers 61 esophageal cancers 61 precancerous cervical lesions 61 rectal cancers 61 cervical breast 61 lobular breast cancer 60 squamous cell carcinoma 60 PCa 60 pancreatic adenocarcinoma 60 medulloblastomas 60 nonmelanoma skin cancers 60 squamous cell carcinomas 60 ovarian breast 60 cancer 60 NSCLC 60 carcinomas 60 BRCA mutation 60 HPV 60 lobular cancer 60 carcinoma 60 pancreatic lung 60 metastatic disease 60 precancerous lesions 60 malignant tumors 60 basal cell carcinoma BCC 60 lobular carcinoma 60 oropharyngeal cancer 60 breast endometrial 59 lung adenocarcinoma 59 ductal cancer 59 epithelial ovarian cancer 59 CaP 59 BRCA2 59 advanced adenoma 59 bladder cancer 59 atypical hyperplasia 59 BRCA2 gene mutations 59 breast cancer recurrence 59 genes BRCA1 59 invasive carcinoma 59 HNSCC 59 seminoma 59 medullary thyroid cancer 58 BRCA1 mutations 58 liver cancer 58 liver metastases 58 cutaneous melanoma 58 cervical intraepithelial neoplasia 58 chromosomal abnormalities 58 prostate pancreatic 58 BRCA1 58 precursor lesions 58 Cancers 58 ovarian 58 prostate adenocarcinoma 58 metastatic prostate cancer 58 curable cancers 58 soft tissue sarcomas 58 Ovarian cancer 58 serous ovarian cancer 58 metastatic breast cancer 58 cervical lesions 58 uveal melanoma 58 testicular germ cell 58 nasopharyngeal carcinoma 58 breast carcinomas 58 nonsmall cell lung cancer 58 cervical carcinoma 58 medulloblastoma 58 inherited mutations 58 brain tumors 58 HER2 positive 58 colorectal polyps 58 distant metastases 58 estrogen receptor negative 58 squamous cell 58 prostate cancer CaP 58 adenomas 58 mesotheliomas 57 renal cell carcinomas 57 metastatic colorectal 57 human papillomavirus HPV 57 grade gliomas 57 HPV infections 57 DCIS 57 sarcomas 57 neoplasia 57 familial pancreatic cancer 57 BRCA2 gene mutation 57 gene BRCA2 57 leukaemias 57 squamous cell cancers 57 neuroblastomas 57 uterine ovarian 57 advanced adenomas 57 colorectal polyp 57 pre cancerous 57 ductal breast cancer 57 colon breast 57 invasive ductal 57 breast carcinoma 57 colorectal 57 postmenopausal breast cancer 57 rectal cancer 57 neoplasias 57 pre cancerous polyps 57 breast cancer genes BRCA1 56 BRCA deficient 56 penile cancers 56 carcinoid tumors 56 estrogen receptor positive 56 peritoneal cancer 56 epithelial tumors 56 ALCL 56 bowel cancer 56 operable breast cancer 56 atypia 56 HER2 negative 56 precancers 56 HPV types 56 cell lung cancer 56 oesophageal cancer 56 mammary tumors 56 GBM tumors 56 HPV infection 56 pleural mesothelioma 56 hepatocellular carcinoma HCC 56 sarcoma 56 malignant melanomas 56 lung colorectal 56 adenoma 56 glioblastoma 56 prostate lung 56 prostate ovarian 56 BRCA1 gene 56 BRCA2 mutation 56 mutated BRCA1 56 metastatic melanoma 56 colorectal adenomas 56 venous blood clots 56 leiomyosarcoma 56 acute myelogenous leukemia AML 56 pancreatic tumors 56 pancreatic cancer 56 carcinoid cancer 56 hepatocellular cancer 56 uterine cancer 56 CMV infection 56 hepatocellular carcinoma 56 squamous cell carcinoma SCC 56 lymphoma 56 skeletal metastases 56 ovarian carcinoma 56 BRCA2 carriers 55 systemic scleroderma 55 gastric adenocarcinoma 55 breast uterine 55 benign growths 55 tumor recurrence 55 recurrent ovarian cancer 55 metastatic colon cancer 55 BRCA genes 55 gynecologic cancer 55 premalignant 55 chlamydial infection 55 intestinal polyps 55 epithelial cancers 55 BRCA1 mutation carriers 55 precancerous polyps 55 melanoma tumors 55 colorectal carcinoma 55 distant metastasis 55 osteosarcomas 55 HER2 55 adjuvant therapy 55 endometrial hyperplasia 55 breast pancreatic 55 HER2 overexpression 55 situ LCIS 55 BRCA2 mutation carriers 55 EGFR mutations 55 ErbB2 positive 55 nonmelanoma skin cancer 55 Gastric cancer 55 prostate carcinoma 55 grade cervical intraepithelial 55 genital herpes infections 55 endometrial carcinoma 55 ALK mutations 55 HER2 positive cancers 55 renal cell carcinoma 55 MYCN amplification 55 Malignant Melanoma 55 CMV disease 55 esophageal tumors 55 malignant pleural mesothelioma 55 gliomas 55 CIN2 + 55 epithelial ovarian 55 advanced neoplasia 55 FGFR2 55 breast prostate 55 familial ALS 55 vaginal cancers 55 neuroendocrine cancers 55 PARP inhibition 55 Her2 54 gene mutations 54 cervical dysplasia 54 pelvic malignancies 54 molecular abnormalities 54 Adjuvant chemotherapy 54 follicular lymphoma 54 pancreatic prostate 54 prostate specific 54 HCV infection 54 Uterine cancer 54 lobular carcinomas 54 neoplasms 54 metastatic 54 colo rectal cancer 54 testicular tumors 54 periodontitis 54 benign polyps 54 ovarian lung 54 lung pancreatic 54 mammary cancers 54 HER2 positive tumors 54 Colorectal cancer 54 leukemias 54 HPV# 54 prostate breast 54 castrate resistant 54 basal cell carcinoma 54 synovial sarcoma 54 lung adenocarcinomas 54 urothelial carcinoma 54 choriocarcinoma 54 colorectal gastric 54 micrometastases 54 pheochromocytomas 54 breast cancer recurrences 54 Glioblastoma 54 EGFR mutation 54 squamous cell cancer 54 BRCA2 gene 54 colorectal lung 54 colorectal breast 54 leukemia ALL 54 olaparib 54 ependymoma 54 malignant growths 54 polyps 54 Carcinoma 54 esophageal squamous cell carcinoma 54 Breast cancer 54 acute leukemias 54 cancerdefine 54 vulvar cancers 54 carcinoid 54 PARP inhibitors 54 gastrointestinal stromal tumors 54 lymph node metastases 54 ovarian pancreatic 54 ependymomas 54 endometrial 54 type 1diabetes 54 cell carcinoma 54 tyrosine kinase inhibitors 54 pre menopausal 54 invasive ductal carcinoma 54 BRCA 54 fallopian tube carcinoma 54 hormone receptor positive 54 HNPCC 53 p# mutations 53 HCV infections 53 HGPIN 53 IV melanoma 53 invasive cervical cancers 53 ccRCC 53 thyroid nodules 53 Colon polyps 53 metastatic bladder 53 prostrate cancer 53 CIN2 53 BRCA mutation carriers 53 oophorectomy 53 ovarian cervical 53 brain metastases 53 squamous cell lung cancer 53 pancreatic NET 53 mutated KRAS gene 53 polycystic ovary syndrome PCOS 53 KRAS mutations 53 metastatic HER2 positive 53 external genital lesions 53 glioma 53 BRCA1 mutation 53 colon polyps 53 Barrett esophagus 53 metastatic prostate 53 metastatic lesions 53 adjuvant radiation 53 situ DCIS 53 glioblastomas 53 malignant lymphoma 53 breast colon 53 cancerous tumors 53 metastatic lung cancer 53 tumor subtypes 53 cell carcinomas 53 precancer 53 NF1 53 basal cell skin 53 Stomach cancer 53 commonly mutated genes 53 ADPKD 53 overexpress HER2 53 bone metastasis 53 tamoxifen 53 tamoxifen therapy 53 estrogen progestin therapy 53 transitional cell carcinoma 53 Li Fraumeni 53 Renal cell carcinoma 53 pituitary tumors 53 metastasis 53 diffuse gastric 53 cisplatin resistant 53 Testicular cancer 53 prostate cancer PCa 53 urothelial cancer 53 NAFLD 53 Squamous cell 53 renal carcinoma 53 Gliomas 53 Epstein Barr virus EBV 53 progesterone receptor negative 53 antigen PSA 53 Hepatocellular Carcinoma HCC 53 solid tumors 53 BRCA gene mutations 53 PARP inhibitor 53 axillary dissection 53 histological subtype 53 bladder tumors 53 prostate tumor 53 urothelial bladder cancer 53 breast cancer metastasis 53 cetuximab Erbitux 53 BRAF gene 53 axillary lymph nodes 53 endostatin 53 MGUS 53 precancerous colon polyps 53 ductal carcinomas 53 myelodysplastic syndrome MDS 53 vulvar cancer 53 BRCA carriers 53 squamous cell skin 52 ductal adenocarcinoma 52 gynecologic malignancy 52 familial adenomatous polyposis 52 abnormal mammograms 52 Lung cancer 52 pre cancerous growths 52 benign breast 52 benign tumors 52 untreated celiac disease 52 malignant polyps 52 tumor 52 Tumors 52 peritoneal carcinomatosis 52 ductal lobular 52 TGFBR1 * 6A 52 BRAF mutations 52 Metastatic breast cancer 52 EUS FNA 52 fibroadenomas 52 Cervical cancer 52 gastric carcinoma 52 metastatic tumors 52 anaplastic 52 Wilms tumor 52 PTEN mutations 52 gynecological cancer 52 K ras mutations 52 Metastases 52 faulty BRCA genes 52 hormone receptor negative 52 ovarian endometrial 52 MSH2 52 basal cell 52 recurrent miscarriage 52 CIN3 52 pre cancerous cells 52 neoadjuvant chemotherapy 52 Tumours 52 hormonal therapies 52 papillary 52 nonmetastatic 52 hormonal therapy 52 metastatic colorectal cancer 52 metastatic renal cell carcinoma 52 basal cell nevus syndrome 52 Glioma 52 precancerous 52 cisplatin 52 GIST tumors 52 esophageal cancer 52 neuroendocrine carcinoma 52 EGFR inhibitors 52 imatinib Gleevec 52 HER2 + 52 renal tumors 52 vaginal lesions 52 Human Papilloma Virus 52 gene mutation 52 hamartomas 52 pancreatic neuroendocrine tumors 52 Prostate cancer 52 endometrial tumors 52 meningiomas 52 familial hypercholesterolemia 52 anthracyclines 52 premalignant lesions 52 metastatic kidney 52 Polyps 52 lung prostate 52 metastatic cancers 52 atypical ductal hyperplasia 52 Adenocarcinoma 52 colorectal pancreatic 52 solar keratosis 52 Colorectal cancers 52 cisplatin chemotherapy 52 Colorectal cancer CRC 52 Cholangiocarcinoma 52 S. aureus infections 52 malignant gliomas 52 angiosarcoma 52 lupus 52 HPV genotypes 52 taxane therapy 52 HER2 receptor 52 atherosclerotic lesions 52 PCNSL 52 Malignant melanoma 52 KRAS oncogene 52 Zolinza 52 glioblastoma tumors 52 oesophageal cancers 52 alveolar rhabdomyosarcoma 52 recurrent metastatic 52 BRCA gene 52 thyroid cancer 52 herpesviruses 52 colorectal bowel 52 cancerous polyps 52 KRAS mutation 52 APOL1 52 ASCUS 52 benign noncancerous 52 papillary thyroid cancer 52 grade serous ovarian 52 germline mutations 51 Hashimoto thyroiditis 51 precancerous growths 51 aneuploidy 51 lung colon 51 grade glioma 51 hormone therapy estrogen 51 superficial bladder cancer 51 ductal carcinoma 51 ovarian prostate 51 basal cell cancers 51 castration resistant prostate cancer 51 recurrent NSCLC 51 prostate cancer CRPC 51 metachronous 51 leiomyomas 51 precancerous polyp 51 oncogenic HPV types 51 gastrointestinal malignancies 51 Acute lymphoblastic leukemia 51 Helicobacter pylori infection 51 prostate colon 51 EGFR 51 polycystic ovarian syndrome PCOS 51 Bladder cancer 51 aneuploidies 51 Human Papillomavirus 51 Melanomas 51 ABCB1 51 colon rectal cancer 51 genetic abnormalities 51 cervical uterine 51 Chlamydia infection 51 oesophageal adenocarcinoma 51 HER2 amplified 51 tumor histology 51 prophylactic mastectomy 51 leukemia AML 51 colorectal neoplasia 51 malignant neoplasm 51 multiple myeloma 51 human papillomavirus 51 mammary cancer 51 breast caner 51 breast cervical 51 differentiated thyroid 51 prostate cancer AIPC 51 neuroblastoma 51 ovarian hyperstimulation syndrome OHSS 51 medically inoperable 51 grade cervical dysplasia 51 androgen independent 51 osteosarcoma 51 pheochromocytoma 51 cutaneous squamous cell carcinoma 51 HPVs 51 Malignant tumors 51 precancerous cervical 51 GSTP1 51 lymphoproliferative disorders 51 CDH1 51 polyp recurrence 51 FSGS 51 adenomatous polyp 51 Basal cell 51 abnormal Pap test 51 endometriosis 51 CYT# potent vascular disrupting 51 neoadjuvant therapy 51 bone metastases 51 esophageal adenocarcinoma 51 resistant ovarian cancer 51 abnormal growths 51 LRP5 51 T1c 51 thyroid tumors 51 cancerous lesions 51 premature menopause 51 GnRH agonists 51 HBeAg negative 51 colorectal adenoma 51 nonvaccine 51 contralateral breast cancer 51 spontaneous preterm delivery 51 genetic variants associated 51 ovarian uterine 51 frequently benign tumor 51 hereditary breast 51 preeclampsia 51 disease 51 metastatic gastric 51 ZNF# 51 Metastatic 51 cancerous breast 51 abnormal Pap 51 lung carcinomas 51 T#I mutant 51 Human papilloma virus 51 pre malignant lesions 51 EGFR mutant 51 medulloblastoma tumors 51 Uterine fibroids 51 HER-2/neu 51 ocular melanoma 51 sporadic ALS 51 recurrent ovarian 51 breast cancer susceptibility genes 51 cholangiocarcinoma 51 chemoresistance 51 paragangliomas 51 papillary renal cell carcinoma 51 seminomas 51 cardiovascular disease 51 endometrial ovarian 51 HLA B# 51 mammographic density 51 Non Hodgkin lymphoma 51 cervical vulvar 51 heavily pretreated 51 gene variants 51 LQTS 51 Melanoma 51 lymph node metastasis 51 somatic mutations 51 adenoid cystic carcinoma 51 laryngeal cancer 50 chlamydial infections 50 GNAQ 50 adjuvant therapies 50 hormone deprivation 50 lung metastases 50 non Hodgkin lymphoma 50 relapsed ovarian cancer 50 castrate resistant prostate cancer 50 AAT deficiency 50 retinoblastoma 50 Basal cell carcinoma 50 uterine tumors 50 Alzheimers disease 50 erlotinib 50 prolongs survival 50 locoregional recurrence 50 fibrocystic disease 50 trastuzumab 50 B7 H3 50 anal lesions 50 malignant transformation 50 estrogen therapy 50 liver metastasis 50 Anal cancer 50 mtDNA mutations 50 non Hodgkin lymphomas 50 node metastases 50 adjuvant chemotherapy 50 lymph node involvement 50 Carcinoid tumors 50 benign proliferative breast 50 BRAF V#E 50 autoantibodies 50 colorectal neoplasms 50 preterm delivery 50 idiopathic myelofibrosis 50 glioma rarer 50 pre eclampsia 50 SCCHN 50 abnormal cervical 50 FLT3 50 precancerous tumors 50 cyclin E 50 ovaries removed 50 biliary cancer 50 pulmonary metastases 50 premalignant lesion 50 cardiotoxicity 50 liposarcoma 50 Herceptin trastuzumab 50 malignant neoplasms 50 BRCA gene mutation 50 undergone hysterectomy 50 HbF 50 Cell Lung Cancer 50 osteoporotic fractures 50 situ CIS 50 lymphatic tissue 50 cell lymphomas 50 Seewaldt 50 premenopausal breast cancer 50 colorectal cancer screening 50 dutasteride 50 HBV vaccine 50 Brain metastases 50 metastatic carcinoma 50 intestinal metaplasia 50 mutated genes 50 gastrointestinal stromal tumors GISTs 50 T#I [002] 50 p# mutation 50 pituitary adenomas 50 Endometrial cancer 50 Human papillomavirus HPV 50 Epithelial ovarian cancer 50 Human Papilloma Virus HPV 50 pCR 50 acute myeloid leukemia 50 colon lung 50 malignant lesions 50 EGFR tyrosine kinase inhibitors 50 gallstone disease 50 methylation markers 50 gefitinib Iressa 50 MALT lymphoma 50 colorectal carcinomas 50 WT1 50 Squamous 50 Oesophageal cancer 50 PGDH 50 nodular melanoma 50 bladder prostate 50 antiestrogen 50 isoflavones 50 elevated triglyceride levels 50 BRCA2 genes 50 pancreatic islet cell 50 malignant mesothelioma 50 dasatinib 50 cancerous growths 50 proliferative diabetic retinopathy 50 breast lesions 50 invasive meningococcal disease 50 poorer prognosis 50 anovulatory infertility 50 Smac mimetic 50 Papillary 50 benign lesions 50 ovulatory infertility 50 Hodgkin lymphoma HL 50 nucleoside analogues 50 intraepithelial neoplasia 50 aneuploid cells 50 LHRH receptor positive 50 invasive pneumococcal disease 50 Pap smear screening 50 invasive ductal carcinomas 50 Candida infection 50 noncancerous tumors 50 metastatic ovarian cancer 50 NMP# 50 hypermethylated 50 K ras gene 50 myeloid leukemia 50 Pancreatic Cancer 50 metastatic adenocarcinoma 50 Renal Cell Carcinoma RCC 50 Recurrences 50 specific antigen PSA 50 Leukemias 50 chronic lymphocytic leukemia CLL 50 chronic myelogenous leukemia CML 50 Pancreatic cancer 50 Squamous cell carcinomas 50 metastatic melanomas 50 EGFR gene 50 lung nodules 50 IKZF1 50 Toxicities 50 oral squamous cell 50 localized prostate cancer 50 hormone therapy 50 stage IIIB IV 50 mutations 50 nasopharyngeal cancer 50 Osteosarcoma 50 gastrointestinal stromal tumors GIST 50 gastrointestinal GI cancers 50 lipid abnormalities 50 HER2 positive metastatic breast 50 invasive carcinomas 50 alkylating agents 50 astrocytomas 50 chronic HBV infection 50 aromatase inhibitors 50 detecting precancerous 50 Bowel cancer 49 invasive lobular carcinoma 49 cranial radiation 49 dysplastic lesions caused 49 genetic mutations 49 MUC1 49 VUR 49 cervical abnormalities 49 narcolepsy cataplexy 49 microdeletions 49 activating mutations 49 colon esophageal 49 heart disease 49 Basal Cell 49 NNRTI resistance 49 Thyroid nodules 49 prostate carcinomas 49 nonproliferative 49 CIN3 + 49 pathogenic mutations 49 COX2 49 pancreatic tumor 49 ovarian hyperstimulation 49 Adenomas 49 chemoradiation 49 cervical precancers 49 mutated BRAF gene 49 colon pancreas 49 Clusterin 49 hypercalcemia 49 hormone refractory 49 KRAS status 49 specific antigen 49 gefitinib 49 commercialize deforolimus 49 urinary bladder cancer 49 HER2 positive breast 49 digestive tract cancers 49 exemestane 49 PSA screening 49 prostate cancer mCRPC 49 Cristofanilli 49 distal colon cancer 49 papillary carcinoma 49 colorectal prostate 49 thromboembolic events 49 TOP2A 49 Digital Mammographic Imaging 49 pT2 49 mitochondrial diseases 49 chronic hepatitis 49 genital wart cases 49 telomere lengths 49 EBRT 49 postoperative delirium 49 non metastatic osteosarcoma 49 SLNB 49 estrogen receptor ER 49 cetuximab 49 lobular involution 49 symptomless 49 Her-2/neu 49 myeloproliferative diseases 49 radiation therapy SBRT 49 pertuzumab 49 pancreatic ovarian 49 TCF#L# 49 liver fibrosis 49 breast cancer gene mutations 49 venous thrombosis 49 cirrhosis liver failure 49 TT genotype 49 castration resistant 49 HGS ETR1 49 CC genotype 49 PALB2 49 Epstein Barr virus 49 recurrences 49 Li Fraumeni syndrome 49 anticancer drugs 49 sarcosine 49 respiratory viral infections 49 ovarian tumor 49 bladder ovarian 49 pneumococcal strains 49 Gardasil protects 49 leukemia CLL 49 chromosomal rearrangement 49 nodal metastasis 49 sentinel nodes 49 cancer metastasizes 49 lung cancer NSCLC 49 chronic periodontitis 49 pancreatic carcinoma 49 Esophageal cancer 49 dysglycemia 49 intraductal 49 alpha carotene 49 H. pylori infection 49 neuroblastoma tumors 49 Rectal cancer 49 melanoma lesions 49 hereditary predisposition 49 GIST 49 chlamydia infection 49 Glioblastoma multiforme 49 atrophic gastritis 49 HRPC 49 genistein 49 Human Papillomavirus HPV 49 bile duct cancers 49 promoter hypermethylation 49 ovulations 49 T#I mutation 49 low expressors 49 aromatase inhibitor 49 mRCC 49 carcinoma HNSCC 49 prostate cancer HRPC 49 HIV HCV coinfected 49 embryonal rhabdomyosarcoma 49 breast cancer subtypes 49 yearly mammograms 49 acute myeloid leukemia AML 49 leukemias lymphomas 49 acute lymphoid leukemia 49 KRAS mutations occur 49 basal cell cancer 49 genital tract infections 49 Rhabdomyosarcoma 49 colon pancreatic 49 E#F# 49 oligodendrogliomas 49 Colorectal cancer screening 49 abnormal glucose tolerance 49 fallopian tube cancers 49 recurrent VTE 49 BRAF mutation 49 PSADT 49 anticancer agents 49 pre cancerous lesion 49 breast cancer gene mutation 49 androgenetic alopecia 49 androgens 49 chromosomal anomalies 49 geographic atrophy 49 astrocytoma 49 abnormal Pap tests 49 papillomaviruses 49 Glioblastoma Multiforme 49 PKCi 49 abnormal mammogram 49 gastrointestinal stromal tumor 49 Gleevec resistant 49 ARVD 49 resectable 49 Sezary syndrome 49 lobular 49 beta thalassemia 49 metastatic RCC 49 chronic prostatitis 49 asymptomatic 49 perimenopausal women 49 NF2 49 oropharyngeal squamous cell carcinoma 49 HPV subtypes 49 oncoplastic 49 malignant pancreatic 49 lobules 49 imatinib resistance 49 eribulin 49 TOMM# 49 essential thrombocythemia 49 genetic abnormality 49 BRCA1 BRCA2 49 dysplastic nevi 49 abnormal cytology 49 DHFR 49 hemorrhagic strokes 49 thrombotic events 49 mitochondrial fusion 49 penetrance 49 ovarian colorectal 49 chemoradiotherapy 49 elevated CRP 49 Alessandro Riva 49 trans retinoic acid 49 recurrent UTI 49 oesophageal 49 spontaneous preterm birth 49 tumors GIST 49 PNET 49 squamous